Curium Drug Patent Portfolio
Curium owns 2 orange book drugs protected by 4 US patents Given below is the complete list of Curium's drugs and the patents protecting them.
1. Octreoscan
Octreoscan is protected by 3 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6123916 | Therapeutic use of somatostatin peptides |
26 Sep, 2017
(6 years ago)
| Expired |
| US5776894 | Chelated somatostatin peptides and complexes thereof, pharmaceutical compositions containing them and their use in treating tumors |
07 Jul, 2015
(9 years ago)
| Expired |
| US5753627 | Use of certain complexed somatostatin peptides for the invivo imaging of somatostatin receptor-positive tumors and metastasis |
19 May, 2015
(9 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Octreoscan's drug page
2. Technescan Mag3
Technescan Mag3 is protected by 1 patent, which has expired already. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US5573748 | Radiolabeled technetium chelates for use in renal function determinations |
12 Nov, 2013
(10 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Technescan Mag3's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List